Quest Diagnostics Incorporated (DGX)
NYSE: DGX · IEX Real-Time Price · USD
144.72
+0.38 (0.26%)
May 20, 2024, 10:27 AM EDT - Market open
Quest Diagnostics Market Cap
Quest Diagnostics has a market cap or net worth of $16.09 billion as of May 20, 2024. Its market cap has increased by 9.74% in one year.
Market Cap
16.09B
Enterprise Value
20.91B
1-Year Change
9.74%
Ranking
Category
Stock Price
$144.72
Market Cap Chart
Since December 1, 1998, Quest Diagnostics's market cap has increased from $531.80M to $16.09B, an increase of 2,925.05%. That is a compound annual growth rate of 14.32%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 16.04B | 1.34% |
May 16, 2024 | 15.82B | 1.17% |
May 15, 2024 | 15.64B | 1.16% |
May 14, 2024 | 15.46B | -1.15% |
May 13, 2024 | 15.64B | 1.71% |
May 10, 2024 | 15.38B | 0.19% |
May 9, 2024 | 15.35B | 1.48% |
May 8, 2024 | 15.12B | -0.58% |
May 7, 2024 | 15.21B | 0.96% |
May 6, 2024 | 15.07B | -1.27% |
May 3, 2024 | 15.26B | 0.76% |
May 2, 2024 | 15.15B | -0.88% |
May 1, 2024 | 15.28B | -0.46% |
Apr 30, 2024 | 15.35B | -0.95% |
Apr 29, 2024 | 15.50B | 3.90% |
Apr 26, 2024 | 14.92B | -0.86% |
Apr 25, 2024 | 15.04B | -1.55% |
Apr 24, 2024 | 15.28B | 0.97% |
Apr 23, 2024 | 15.13B | 5.08% |
Apr 22, 2024 | 14.40B | 1.28% |
Apr 19, 2024 | 14.22B | 2.01% |
Apr 18, 2024 | 13.94B | -0.84% |
Apr 17, 2024 | 14.06B | -0.35% |
Apr 16, 2024 | 14.11B | -0.95% |
Apr 15, 2024 | 14.24B | 0.09% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Teva Pharmaceutical | 18.30B |
Baxter International | 17.97B |
Laboratory Corporation of America Holdings | 17.72B |
Illumina | 17.65B |
Hologic | 17.51B |
Walgreens Boots Alliance | 15.67B |
BioMarin Pharmaceutical | 14.74B |
Neurocrine Biosciences | 14.30B |